FAILURE OF 19-HYDROXYLATED ANDROGENS TO INHIBIT COMPENSATORY OVARIAN HYPERTROPHY IN THE RAT

in Journal of Endocrinology
Authors:
R. F. PARROTT
Search for other papers by R. F. PARROTT in
Current site
Google Scholar
PubMed
Close
and
J. E. BOOTH
Search for other papers by J. E. BOOTH in
Current site
Google Scholar
PubMed
Close
Restricted access
Rent on DeepDyve

Sign up for journal news

Department of Physiology, Royal Veterinary College, London, NW1 OTU

(Received 21 August 1975)

19-Hydroxytestosterone (17β-hydroxy-4-androsten-19-ol-3-one; 19HT) and its 5α-reduced metabolite (17β-hydroxy-5α-androstan-19-ol-3-one; 5α-19HT)have negligible stimulatory effects on androgen target organs in the castrated rat (Parrott, 1974, 1975). The object of this study was to establish whether these androgens can limit the release of luteinizing hormone (LH) from the pituitary. To investigate this they were compared with testosterone for their ability to prevent compensatory ovarian hypertrophy in the unilaterally ovariectomized rat.

Forty-eight adult female Sprague-Dawley (MRC) rats were hemi-ovariectomized and allocated to six groups of eight animals each. Body weights and the weight of the left ovary were recorded. Starting from ovariectomy, rats received ten daily 0·2 ml s.c. injections after which they were killed. Treatments were oil vehicle (control); testosterone, 1 mg/day; 19HT, 1 mg/day; 19HT, 2 mg/day; 5α-19HT, 1 mg/day; 5α-19HT, 2 mg/day. All solutions were kept on a hotplate

 

  • Collapse
  • Expand